Jasper Therapeutics, Inc., (JSPR): Price and Financial Metrics

Jasper Therapeutics, Inc., (JSPR): $5.40

0.09 (-1.64%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add JSPR to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#300 of 304

in industry

JSPR Price/Volume Stats

Current price $5.40 52-week high $26.83
Prev. close $5.49 52-week low $3.13
Day low $5.22 Volume 87,945
Day high $5.61 Avg. volume 450,634
50-day MA $4.91 Dividend yield N/A
200-day MA $14.45 Market Cap 81.12M

JSPR Stock Price Chart Interactive Chart >


Jasper Therapeutics, Inc., (JSPR) Company Bio


Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company develops JSP191, a humanized monoclonal antibody for clearing hematopoietic stem cells from bone marrow in patients undergoing a hematopoietic cell transplantation. It also develops Jasper eHSC Platform to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.


JSPR Latest News Stream


Event/Time News Detail
Loading, please wait...

JSPR Latest Social Stream


Loading social stream, please wait...

View Full JSPR Social Stream

JSPR Price Returns

1-mo 30.43%
3-mo -10.89%
6-mo -74.61%
1-year -77.49%
3-year -85.68%
5-year -94.46%
YTD -74.74%
2024 170.98%
2023 63.39%
2022 -93.85%
2021 -21.58%
2020 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!